You are here: Industry Insights > Magenta Therapeutics

News List

Avrobio and Magenta Therapeutics Collaborate contractpharma
May 07, 2020
Evaluate targeted antibody-drug conjugate as a potential conditioning regimen for lentiviral gene therapies.
Magenta stem cell transplant drug seems to work, but is it safe? fiercebiotech
November 02, 2018
Magenta’s stem cell therapy MGTA-456 met efficacy targets in the first few patients enrolled in a phase 2 trial to be presented at ASH next month, but with a question about safety.
Magenta Therapeutics Snags $52 Million to Advance Bone Marrow Transplant Medications biospace
April 10, 2018
Fresh off of striking a research deal with Ladenburg, Germany-based Heidelberg Pharma GmbH, Magenta Therapeutics secured $52 million in Series C financing.
Magenta Therapeutics collaborates with Heidelberg Pharma for Bone Marrow Transplants biospace
March 07, 2018
Cambridge, Massachusetts-based Magenta Therapeutics is teaming up with Ladenburg, Germany-based Heidelberg Pharma GmbH to improve curative bone marrow transplantation.